Ronald Blue Trust, Inc. Acadia Pharmaceuticals Inc Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 544 shares of ACAD stock, worth $9,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
544
Previous 782
30.43%
Holding current value
$9,520
Previous $14,000
35.71%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$750 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$244 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$211 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$152 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$128 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.83B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...